Nutriband Inc. NTRB
Set alert
6.30 USD -0.34 -5.12%
At close · Oct 30
6.30 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
6.20 Day range 6.42
2.81 52-week range 8.99
- YTD
- +38.77%
- 1 year
- -8.83%
- Open
- 6.30
- Prev close
- 6.64
- Mkt cap
- 76.58M
- Vol
- 22.23K
- Avg vol
- 68.47K
- EPS
- -0.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.20
- High
- 6.42
- Forward P/E
- -17.30
- Beta
- 0.42
- Short ratio
- 1.53
- Inst. own
- 2.38%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.30
- 200-d avg
- 5.09
- 1y target
- 0.00
2Y chart
Events in this range
- Dec 3, 2024Earnings: -0.12; estimate 0; surprise —%
Signals (85)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Sep 3, 2026 | 1 month ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| RSI: Oversold | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 10, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 3, 2026 | 9 months ago |
| SMA: Bullish | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 23, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Dec 30, 2025 | 10 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 4, 2025 | 11 months ago |
| RSI: Oversold | Dec 3, 2025 | 11 months ago |
| RSI: Oversold | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 15, 2025 | 1 year ago |
| RSI: Overbought | Oct 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| SMA: Bearish | Sep 4, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 27, 2025 | 1 year ago |
| SMA: Bullish | Aug 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 2, 2025 | 1 year ago |
| RSI: Overbought | Jul 2, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 14, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| RSI: Overbought | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| SMA: Bearish | Mar 18, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 6, 2025 | 1 year ago |
| RSI: Overbought | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 16, 2025 | 1 year ago |
| RSI: Oversold | Nov 29, 2024 | 1 year ago |
| RSI: Oversold | Nov 21, 2024 | 1 year ago |
Key statistics
- Market cap
- 44.20M
- Enterprise value
- 44.16M
- Trailing P/E
- 0.00
- Forward P/E
- -17.30
- PEG ratio
- 0.00
- Price / sales
- 21.92
- Price / book
- 5.47
- EPS (TTM)
- -0.71
- Beta
- 0.42
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 2.02M
- Revenue growth
- -14.30%
- Free cash flow
- -1.55M
- Total cash
- 8.35M
- Total debt
- 527.92K
- Return on equity
- -60.41%
- Shares outstanding
- 11.11M
- Short % of float
- 1.00%
- 50-day average
- 5.30
- 200-day average
- 5.09
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
NTRB Revenue — quarterly 437.51K
NTRB Net income — quarterly -880.56K
NTRB EPS — quarterly -0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 3, 2024 | Oct 1, 2024 | 0.00 | -0.12 | — | — |
| Sep 3, 2024 | Jul 1, 2024 | 0.00 | -0.12 | — | — |
| May 31, 2024 | Apr 1, 2024 | 0.00 | -0.21 | — | — |
| Apr 30, 2024 | Jan 1, 2024 | 0.00 | -0.16 | — | — |
| Dec 12, 2023 | Oct 1, 2023 | 0.00 | -0.22 | — | — |
| Sep 11, 2023 | Jul 1, 2023 | 0.00 | -0.11 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 26, 2022 | Small Cap Consumer Research | main | — | Buy |
About Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- nutriband.com
News
- Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
- Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal Technology
- Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
- Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
- Head to Head Contrast: ARS Pharmaceuticals (NASDAQ:SPRY) and Nutriband (NASDAQ:NTRB)
- Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
Your note
Sign in to keep a note on NTRB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MELNIK SERGUEI | President | Stock Gift | Mar 5, 2023 | 827,999 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.86% | 118,063 | 469.89K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.91% | 58,063 | 231.09K | Sep 29, 2024 |
| UBS Group AG | 0.32% | 20,352 | 81.00K | Sep 29, 2024 |
| Avantax Advisory Services, Inc. | 0.29% | 18,678 | 74.34K | Sep 29, 2024 |
| State Street Corporation | 0.27% | 17,266 | 68.72K | Sep 29, 2024 |
| Farther Finance Advisors, Llc | 0.25% | 16,014 | 63.73K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.13% | 71,575 | 284.87K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.69% | 43,788 | 174.28K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.46% | 29,333 | 116.75K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.16% | 9,882 | 39.33K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 7,260 | 28.89K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.11% | 6,718 | 26.74K | Oct 30, 2024 |